Experimental Lachesis muta rhombeata envenomation and effects of soursop (Annona muricata) as natural antivenom

In the Atlantic forest of the North and Northeast regions of Brazil, local population often uses the fruit juice and the aqueous extract of leaves of soursop (Annona muricata L.) to treat Lachesis muta rhombeata envenomation. Envenomation is a relevant health issue in these areas, especially due to its severity and because the production and distribution of antivenom is limited in these regions. The aim of the present study was to evaluate the relevance of the use of soursop leaf extract and its juice against envenomation by Lachesis muta rhombeata. Methods We evaluated the biochemical, hematological and hemostatic parameters, the blood pressure, the inflammation process and the lethality induced by Lachesis muta rhombeata snake venom. We also assessed the action of the aqueous extract of leaves (AmL) and juice (AmJ) from A. muricata on the animal organism injected with L. m. rhombeata venom (LmrV) in the laboratory environment. Results LmrV induced a decrease of total protein, albumin and glucose; and increase of creatine kinase, aspartate aminotransferase, and urea concentrations. It provoked hemoconcentration followed by reduction of hematocrit, an increase in prothrombin time and partial thromboplastin time and a decrease of the blood pressure. LmrV induced the release of interleukin-6, an increase in neutrophils and changes in the serum protein profile, characteristic of the acute inflammatory process. LD50 values were similar for the groups injected with LmrV and treated or untreated with AmJ and AmL. Both treatments play a role on the maintenance of blood glucose, urea and coagulation parameters and exert a protective action against the myotoxicity. However, they seem to worsen the hypotension caused by LmrV. Conclusion The treatments with AmJ and AmL present some beneficial actions, but they might intensify some effects of the venom. Therefore, additional studies on A. muricata are necessary to enable its use as natural antivenom for bushmaster snakebite.

Caracterización biológica y acción de inhibidores de una fosfolipasa A2 del veneno de Lachesis muta / Biological characterization and inhibitors action of Phospholipase A2 from Lachesis muta venom

El presente trabajo informa de la purificación y caracterización bioquímica y biológica de la fosfolipasa A2 (PLA2) de Lachesis muta (Linnaeus, 1766). La purificación se realizó por cromatografía liquida (CL) usando CM-Sephadex C-50 y Sephadex G-50, obteniéndola al estado homogéneo con un peso molecular de 18749 Da. Los ensayos con PLA2 realizados sobre fosfolípidos de yema de huevo y lecitina comercial, mostraron que los agentes EDTA, PMSF, glutatión y cisteína, inhibieron la actividad con valores mayores al 50%. La PLA2 de L. muta produjo un notable efecto anticoagulante, observándose un retardo de 2'30' en el tiempo de coagulación con 9,6 microgramos de la enzima. La hemólisis indirecta sobre eritrocitos humanos dio un equivalente de 4,35 microgramos como dosis hemolítica media (HD50). Los valores de dosis edemática media y dosis miotóxica mínima fueron de 91,5 microgramos y 125,89 microgramos/mL respectivamente; valores por debajo de PLA2 de otros venenos. No se registró actividad hemorrágica directa. Las pruebas de inmunodifusión e inmunoelectroforésis revelaron que PLA2 de L. muta tuvo reactividad inmunogénica contra el antiveneno lachésico monovalente (INS-Perú). Sin embargo, la neutralización por el antiveneno fue parcial.

In the present study, phospholipase A2 (PLA2) from Lachesis muta (Linnaeus, 1766), is isolated, purified and characterized biochemically and biologically. Purification was performed by liquid chromatography (LC) using CM-Sephadex C-50 and Sephadex G-50, homogenized enzyme had a molecular weight of 18749 Da. Trials with egg yolk phospholipids, and commercial lecithin showed that EDTA, PMSF, glutathione and cysteine inhibited the activity with values greater than 50%. The PLA2 had a significant anticoagulant effect, showing a delay of 2'30" on the coagulation time with 9.6 microgramos of the enzyme. The indirect impact on human erythrocyte hemolysis gave an equivalent of 4.35 microgramos as HD50. Mean edematic dose and minimum myotoxic dose were 91.5 mg and 125.89 mg / mL respectively, these values were below enzymes phospholipase A2 from others poisons. There was no hemorrhagic activity. Immunodiffusion tests and immunoelectrophoresis revealed that the PLA2 of L. muta was immunogenic reactivity against lachesic monovalent antivenom (INS-Peru). However, the neutralization by the antivenom was partial.